PlumX Metrics
Embed PlumX Metrics

Building new drug delivery systems: In vitro and in vivo studies of drug-hydroxybutenyl cyclodextrin complexes

ACS Symposium Series, ISSN: 1947-5918, Vol: 1017, Page: 31-64
2009
  • 2
    Citations
  • 3
    Usage
  • 12
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Conference Paper Description

In many respects, drug delivery is the perfect field for an organic chemist whose interest lies in structure-property relationships. Synthesis and characterization of a drug delivery system and subsequent introduction of a drug product incorporating this drug delivery technology into animals or humans is a complex and challenging structure-property problem. In this regard, we have developed hydroxybutenyl cyclodextrin (HBenCD) for oral and intravenous delivery of pharmaceutical actives having poor water solubility and low bioavailability. In this chapter, we summarize our recent research involving the synthesis and characterization of HBenCD, formation of drug-HBenCD complexes, in vitro solubility and dissolution studies of drug-HBenCD complexes, and pharmacokinetic studies in animals after oral and intravenous administration of drug-HBenCD complexes. © 2009 American Chemical Society.

Bibliographic Details

Charles M. Buchanan; Norma L. Buchanan; Kevin J. Edgar; James L. Little; Michael G. Ramsey; Karen M. Ruble; Vincent J. Wacher; Michael F. Wempe; Sandra Klein

American Chemical Society (ACS)

Chemistry; Chemical Engineering

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know